Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
R&D ‘Recoupment’ Data Demands To Inform Medicare Negotiation Are Unworkable, CMS Told
Jun 19 2023
•
By
Cathy Kelly
CMS Advised To Accept Manufacturer Attestations About R&D Spending • Source: Shutterstock
More from Market Access
More from Pink Sheet